The Rituxirel 100mg Rituximab Injection is made available by us that is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. At present, Rituximab is the most important mAb of clinical value in patients with B-cell lymphoid malignancies. It is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis. It is a type of medication called a monoclonal antibody. It works by attaching to certain blood cells from your immune system (B cells) and killing them. Rituxirel 100mg Rituximab Injection is very useful.